News
Colchicine reduces inflammatory markers associated with metabolic syndrome
- Author:
- Michele G. Sullivan
Colchicine was linked to lower levels of inflammatory markers and improved fasting insulin levels and glucose effectiveness.
News
Deuterium-altered ruxolitinib may be an effective treatment for alopecia areata
- Author:
- Michele G. Sullivan
WASHINGTON – About half of those who took 8 mg of CPT-543, a chemically altered form of ruxolitinib, twice a day for 24 weeks, regrew hair –by at...
News
Abatacept appears safe for RA patients with COPD
- Author:
- Michele G. Sullivan
A large prescription database review found no significantly increased risks of COPD exacerbation, pneumonia, flu, or bronchitis.
News
Amyloid brain imaging changed clinical management in 60% of MCI and dementia patients
- Author:
- Michele G. Sullivan
Results from IDEAS, a prospective imaging study, refined Alzheimer’s disease diagnoses in both amyloid-positive and amyloid-negative cases. Now it...
News
Corticosteroids: What is their place in pneumonia and sepsis?
- Author:
- Michele G. Sullivan
Two experts drew on both personal experience and extant literature in the debate “Steroids for Pneumonia and Sepsis ... Do You Believe?”
News
Hospitalists can make a difference in disasters
- Author:
- Michele G. Sullivan
When fire is eating entire neighborhoods, or a hurricane is smashing towns like toys, the hospitalist will...
News
Total plasma tau correlates with dementia onset, Alzheimer’s disease
- Author:
- Michele G. Sullivan
It’s not the Holy Grail of a simple Alzheimer’s blood test for the clinic. But it could be a big benefit in the...
News
BTK inhibitor calms pemphigus vulgaris with low-dose steroids
- Author:
- Michele G. Sullivan
WASHINGTON – PRN1008 blocks BTK receptors on B cells, thus forestalling the B-cell mediated inflammatory cascade.
Opinion
IV ketamine, intranasal esketamine likely to ‘happily coexist’
- Author:
- Michele G. Sullivan
“Initially, not every psychiatrist will be able to offer esketamine ... and that’s probably okay.”
News
FDA approves intranasal esketamine for refractory major depressive disorder
- Author:
- Michele G. Sullivan
Under the FDA-required REMS, prescribers must complete specific training; the drug must be adminstered in office to allow for patient monitoring...
News
Bermekimab reduces lesions, cuts pain in patients with hidradenitis suppurativa
- Author:
- Michele G. Sullivan
WASHINGTON – The human monoclonal antibody is the first to target interleukin-1 alpha in the disorder.
News
Many common dermatologic drugs can be safely used during pregnancy
- Author:
- Michele G. Sullivan
WASHINGTON – With some caution, it’s possible to continue agents for psoriasis, atopic dermatitis, and pemphigus.
News
Texting improves postpregnancy hypertension monitoring in black women
- Author:
- Michele G. Sullivan
LAS VEGAS – Compared with an office visit, the phone text system virtually eliminated the difference between the number of nonblack and black...
News
Selinexor hits FDA stumbling block
- Author:
- Michele G. Sullivan
The Oncologic Drugs Advisory Committee expressed concern about the high rate of serious adverse events with the drug being developed to treat...
News
FDA: More safety data needed for 12 sunscreen active ingredients
- Author:
- Michele G. Sullivan
Only two – titanium dioxide and zinc oxide – are generally recognized as safe and effective and not misbranded, officials said.